SCHEMBL30800446

SCHEMBL30800446

CC(C)(C)OC(=O)N[C@H]1CC[C@@H](Oc2ccc(Br)nc2C(=O)O)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.42
MAOB P27338 1/20 0.42
BTK Q06187 6/20 0.41
PIK3CD O00329 2/20 0.40
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37
JAK1 P23458 3/20 0.36
CACNB4 O00305 1/20 0.36
CACNA1A O00555 1/20 0.36
CACNA1G O43497 1/20 0.36
CACNG3 O60359 1/20 0.36
CACNA1F O60840 1/20 0.36
CACNA1H O95180 1/20 0.36
CACNB3 P54284 1/20 0.36
CACNA2D1 P54289 1/20 0.36
CACNG7 P62955 1/20 0.36
CACNA1B Q00975 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25937200 1.00 KDM1A (0.42) KDM1AMAOBBTKPIK3CDKMT2A
SCHEMBL25937197 0.92 PIK3CD (0.40) KDM1AMAOBBTKPIK3CDKMT2A
SCHEMBL30101652 0.92 PIK3CD (0.40) KDM1AMAOBBTKPIK3CDKMT2A
SCHEMBL25937203 0.91 PIK3CD (0.40) KDM1AMAOBBTKPIK3CDKMT2A
SCHEMBL30101675 0.91 PIK3CD (0.40) KDM1AMAOBBTKPIK3CDKMT2A
SCHEMBL25937198 0.83 PIK3CD (0.40) KDM1AMAOBBTKPIK3CDKMT2A
SCHEMBL30101648 0.83 PIK3CD (0.40) KDM1AMAOBBTKPIK3CDKMT2A
SCHEMBL25938752 0.81 PIK3CD (0.43) KDM1AMAOBBTKPIK3CDKMT2A
SCHEMBL30101627 0.80 PIK3CD (0.40) KDM1AMAOBBTKPIK3CDKMT2A
SCHEMBL25938869 0.80 PIK3CD (0.40) KDM1AMAOBBTKPIK3CDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117715905-A Checkpoint kinase 1 (CHK 1) inhibitors and uses thereof 无界生物公司 2024-03-15 CN disclosed